UPN1070_Guth_5_S9_L002_R1_001.fastq.gz

syn25874926

Created By Elliot Stieglitz estieglitz

age: 0
sex: Male
Uuid: d9b3b8a4-8573-441f-b7a5-30d7f60e7cb9
assay: bisulfite sequencing
organ:
tissue: blood
ageUnit: months
runType: pairedEnd
species: Homo sapiens
studyId: syn51133946
comments:
dataType: chromatin activity
entityId: syn25874926
platform: Illumina NovaSeq 6000
readPair: 1
Component: EpigeneticsAssayTemplate
aliquotID:
diagnosis:
readDepth:
studyName: DHART SPORE Project 3 - A High Content Clinical Trial (ADVL1521) of the MEK Inhibitor Trametinib in Juvenile Myelomonocytic Leukemia (JMML), a Phase II clinical trial
tumorType: Juvenile Myelomonocytic Leukemia
fileFormat: fastq
initiative: DHART-SPORE Project 3
isCellLine: No
readLength: 150
specimenID: UPN1070_Guth_5
assayTarget:
dataSubtype: raw
nf1Genotype: +/-
nf2Genotype: Unknown
individualID: UPN1070_Guth_5
resourceType: experimentalData
fundingAgency: NIH-NCI
isPrimaryCell: Yes
timePointUnit:
parentSpecimenID: UPN1070_Guth_5
nucleicAcidSource: bulk cell
dissociationMethod:
genePerturbationType: Not Applicable
experimentalTimepoint:
specimenPreparationMethod:
genePerturbationTechnology:

UPN1070_Guth_5_S9_L002_R1_001.fastq.gz page is loading…